Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

NCT: NCT05899361 · COMPLETED

NCT IDNCT05899361
StatusCOMPLETED
Start Date2023-08-30
Completion2026-08-26
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.

Frequently Asked Questions

What is A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest?

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest is a clinical trial registered under NCT05899361. Current status: COMPLETED.

What is the status of NCT05899361?

The current status of NCT05899361 (A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest) is: COMPLETED.

When did A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest start?

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest started on 2023-08-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑